04:38 PM EDT, 10/22/2024 (MT Newswires) -- James Edgemond, CFO and Treasurer, on October 21, 2024, sold 7,782 shares in United Therapeutics ( UTHR ) for $2,855,916. Following the Form 4 filing with the SEC, Edgemond has control over a total of 6,978 shares of the company, with 6,978 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000141588924025507/xslF345X05/form4-10222024_041001.xml